Articles that cite
this article:
Effect of angiotensin II and norepinephrine on early growth response genes in the rat kidney
Mark E Rosenberg, Thomas H Hostetter, Stefan Kren, David Chmielewski
Kidney Int 43(3):601. [CrossRef]
The Relationship of Chronic Angiotensin Converting Enzyme Inhibitor Use and Coronary Collateral Vessel Development
Timucin Altin, Mustafa Kilickap, Eralp Tutar, Sibel Turhan, Yusuf Atmaca, Sadi Gulec, Dervis Oral, Cetin Erol
Int Heart J 48(4):435. [CrossRef]
Das Renin-Angiotensin-System bei kardiovaskulären Erkrankungen
Christina Unterberg, Heinrich Kreuzer, Arnd B. Buchwald
Med Klin 93(7):416. [CrossRef]
Total peripheral resistance responsiveness during the development of secondary renal hypertension in dogs
Warwick P Anderson, Amany Shweta, Roger G Evans, Amanda J Edgley, Yi Gao
J Hypertens 25(3):649. [CrossRef]
Local contractile and growth modulators in the myocardium
Victor J. Dzau
Clin Cardiol 16(s2):5. [CrossRef]
Restenosis-an open file
Michael Gottsauner-wolf, David J. Moliterno, A. Michael lincoff, Eric J. Topol
Clin Cardiol 19(5):347. [CrossRef]
Regulation of c-fos, c-jun and c-myc Gene Expression by Angiotensin II in Primary Cultured Rat Astrocytes: Role of ERK1/2 MAP Kinases
Jimmy Delaney, Roselynn Chiarello, David Villar, Umadevi Kandalam, Ana Maria Castejon, Michelle A. Clark
Neurochem Res 33(3):545. [CrossRef]
A novel role for the cyclin-dependent kinase inhibitor p27Kip1 in angiotensin II–stimulated vascular smooth muscle cell hypertrophy
Ruediger C. Braun-dullaeus, Michael J. Mann, Almut Ziegler, Heiko E. Von der leyen, Victor J. Dzau
J Clin Invest 104(6):815. [CrossRef]
A PIVOTAL ROLE FOR TGF-β* IN ATHEROGENESIS?
DAVID J. Grainger, JAMES C. Metcalfe
Biol Rev 70(4):571. [CrossRef]
Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor
Sudeep K. Bose, Willietta Gibson, Shailendra Giri, Narender Nath, Carlton D. Donald
Prostate 69(12):1334. [CrossRef]
Cardiovascular risk factors and collateral artery formation
D. De groot, G. Pasterkamp, I. E. Hoefer
Eur J Clin Invest [CrossRef]
Renal artery stenosis and accelerated atherosclerosis: which comes first?
Cristiano Fava, Pietro Minuz, Paola Patrignani, Alberto Morganti
J Hypertens 24(9):1687. [CrossRef]
Vascular Remodeling in Hypertensive Transgenic Mice.
Naomi Nishijo, Shoko Takamine, Fumihiro Sugiyama, Koichi Kimoto, Keiko Taniguchi, Hisashi Horiguchi, Takesaburo Ogata, Kazuo Murakami, Akiyoshi Fukamizu, Ken-ichi Yagami
Exp Anim 48(3):203. [CrossRef]
Alpha1-adrenoceptors (α1-AR) and vascular smooth muscle cell growth
Brian B. Hoffman, Zhuo-Wei Hu
Prostate 45(s9):29. [CrossRef]
Internephron heterogeneity of growth factors and sclerosis—Modulation of platelet-derived growth factor by angiotensin II
Ryojiro Tanaka, Keisuke Sugihara, Akinori Tatematsu, Agnes Fogo
Kidney Int 47(1):131. [CrossRef]
PATHOGENETIC ROLE OF VASCULAR ANGIOTENSIN-CONVERTING ENZYME IN THE SPONTANEOUSLY HYPERTENSIVE RAT
H. Okunishi, T. Kawamoto, Y. Kurobe, Y. Oka, K. Ishii, T. Tanaka, M. Miyazaki
Clin Exp Pharmacol Physiol 18(9):649. [CrossRef]
REMODELLING OF THE VASCULAR SYSTEM IN RESPONSE TO HYPERTENSION AND DRUG THERAPY
B. I. Levy, M. E. Safar
Clin Exp Pharmacol Physiol 19(s19):33. [CrossRef]
AUTORADIOGRAPHIC LOCALIZATION OF ANGIOTENSIN-CONVERTING ENZYME AND ANGIOTENSIN II BINDING SITES IN EARLY ATHEROMA-LIKE LESIONS IN RABBIT ARTERIES
Maria Zambetis-bellesis, Gregory J. Dusting, Frederick A. O. Mendelsohn, Karen Richardson
Clin Exp Pharmacol Physiol 18(5):337. [CrossRef]
Transforming growth factor alpha and atrial natriuretic peptide in white adipose tissue depots in rats
D. L. Crandall, G. Gordon, H. E. Herzlinger, B.D. Saunders, R. C. Zolotor, P. Cervoni, J.G. Kral
Eur J Clin Invest 22(10):676. [CrossRef]
Angiotensin II Potentiates Vascular Endothelial Growth Factor-Induced Proliferation and Network Formation of Endothelial Progenitor Cells
Toshio Imanishi, Takuzo Hano, Ichiro Nishio
Hypertens Res 27(2):101. [CrossRef]
Polymorphisms of the renin-angiotensin system genes in progressive renal diseases
Hiroaki Yoshida, Valentina Kon, Iekuni Ichikawa
Kidney Int 50(3):732. [CrossRef]
Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts
Guoping Zhou, Jagannadha C. Kandala, Suresh C. Tyagi, Laxmansa C. Katwa, Karl T. Weber
MOL CELL BIOCHEM 154(2):171. [CrossRef]
THE VASCULAR TISSUE ANGIOTENSIN I-CONVERTING ENZYME ACTIVITY AND AORTIC ELASTIN CONTENT IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS FED FISH DIET
Tetsuo Murakami, Masahiko Soga, Toshio Mitsunaga, Hajime Yoshizumi, Hiroyuki Ito
Clin Exp Pharmacol Physiol 21(6):453. [CrossRef]
Vasoactive hormones and renal sclerosis
Jesús Egido
Kidney Int 49(2):578. [CrossRef]
Rodolfo Farhy, Edward Peterson, A Scicli
J Hypertens 15(4):421. [CrossRef]
Effects of angiotensins on cellular hypertrophy and c-fos expression in cultured arterial smooth muscle cells
Dominique Millet, Claude Desgranges, Michel Campan, Alain-Pierre Gadeau, Olivier Costerousse
Eur J Biochem 206(2):367. [CrossRef]
Effects of angiotensin II on bone cells in vitro
Steffen Lamparter, Lothar Kling, Michael Schrader, Reinhard Ziegler, Johannes Pfeilschifter
J Cell Physiol 175(1):89. [CrossRef]
Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF
Sho-ichi Yamagishi, Kazuo Nakamura, Seiji Ueda, Seiya Kato, Tsutomu Imaizumi
Cell Tissue Res 320(3):437. [CrossRef]
The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation
A. C. Calkin, S. Giunti, K. J. Sheehy, C. Chew, V. Boolell, Y. S. Rajaram, M. E. Cooper, K. A. Jandeleit-dahm
Diabetologica 51(9):1731. [CrossRef]
Diabetes Mellitus-Associated Atherosclerosis
Anna C Calkin, Terri J Allen
Am J Cardiovasc Drugs 6(1):15. [CrossRef]
The renin-angiotensin-system in the skin. Evidence for its presence and possible functional implications
U. M. Steckelings, B. M. Czarnelzki
Exp Dermatol 4(6):329. [CrossRef]
Emerging concepts: Angiotensin-converting enzyme inhibition in coronary artery disease
G. B. John mancini
Cardiovasc Drugs Ther 10(s2):609. [CrossRef]
Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease
R. Ferrari, C. Ceconi, S. Curello, P. Pepi, A. Mazzoletti, O. Visioli
Cardiovasc Drugs Ther 10(s2):639. [CrossRef]
Developmental aspects of the Adipose tissue renin-angiotensin system: Therapeutic implications
David L. Crandall, Helen E. Herzlinger, Brian D. Saunders, John G. Kral
Drug Dev Res 32(2):117. [CrossRef]
Increased platelet-derived growth factor in the kidneys of cyclosporin-treated rats
Magdi Shehata, A Meguid El nahas, Elizabeth Barkworth, Geoffrey H Cope, Andrew T Raftery
Kidney Int 46(3):726. [CrossRef]
Histological evaluation of the effects of angiotensin peptides on wound repair in diabetic mice
Kathleen E. Rodgers, Norma Roda, Juan C. Felix, Theresa Espinoza, Sonia Maldonado, Gere Dizerega
Exp Dermatol 12(6):784. [CrossRef]
NITRIC OXIDE SYNTHASE: Role in the Genesis of Vascular Disease
John P. Cooke, md, Victor J. Dzau, md
Ann Rev Med 48(1):489. [CrossRef]
Signals controlling the expression of PDGF
Ron P. H. Dirks, Henri P. J. Bloemers
Mol Biol Rep 22(1):1. [CrossRef]
Increased angiotensin-converting enzyme and type 1 angiotensin receptors in cortical vasculature and tubulointerstitium of chronically rejected human kidney allografts
Mitsuru Ohishi, Makiko Ueda, Shigeru Tanabe, Young-Sin Han, Frederick Ao Mendelsohn, Jia L Zhuo
Nephrology (Carlton) 6(5):223. [CrossRef]
Chronic transplant rejection
Thomas H Hostetter
Kidney Int 46(1):266. [CrossRef]
Determinants of angiotensin II-induced hypertrophy versus hyperplasia in vascular smooth muscle
Gary K. Owens
Drug Dev Res 29(2):83. [CrossRef]
Novel signal transduction targets in cardiovascular disease: Role of platelet-derived growth factor in vascular smooth muscle cell proliferation
Christopher J. Molloy
Drug Dev Res 29(2):148. [CrossRef]
Platelet-derived growth factor regulates actin isoform expression and growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells
Randal S. Blank, Gary K. Owens
J Cell Physiol 142(3):635. [CrossRef]
The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production
A. C. T. M. Peeters, M. G. Netea, B. J. Kullberg, T. Thien, J. W. M. Van der meer
IMMUNOL 94(3):376. [CrossRef]
'Slow Pressor' Hypertension From Low-Dose Chronic Angiotensin II Infusion
AJ Edgley, MM Kett, WP Anderson
Clin Exp Pharmacol Physiol 28(12):1035. [CrossRef]
Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: Risk of chronic renal failure
Janusz Gumprecht, Marcin J. Zychma, Wladyslaw Grzeszczak, Ewa Zukowska-szczechowska
Kidney Int 58(2):513. [CrossRef]
Angiotensin II-induced vascular smooth muscle cell hypertrophy: PDGF A-chain mediates the increase in cell size
Bradford C. Berk, Gadiparthi N. Rao
J Cell Physiol 154(2):368. [CrossRef]
Angiotensin-converting enzyme gene and diabetes mellitus
B. Kennon, J. R. Petrie, M. Small, J. M. C. Connell
Diabetic Med 16(6):448. [CrossRef]
Development of angiotensin (1-7) as an agent to accelerate dermal repair
Kathleen Rodgers, Shiquan Xiong, Juan Felix, Norma Roda, Theresa Espinoza, Sonia Maldonado, Gere Dizerega
Wound Repair Regen 9(3):238. [CrossRef]
The HOPE Study: practical implications for people with diabetes
Brian Kennon, Miles Fisher
Pract Diab Int 17(6):191. [CrossRef]
Mechanical Stretch-Induced Mitogen-Activated Protein Kinase Activation Is Mediated via Angiotensin and Endothelin Systems in Vascular Smooth Muscle Cells
Hiroyuki Hosokawa, Shinya Aiuchi, Toshie Kambe, Yukihiko Hagiwara, Takao Kubo
Biol Pharm Bull 25(12):1588. [CrossRef]
Effects of TCV-116 on Endothelin-1 and PDGF A-Chain Expression in Angiotensin II-Induced Hypertensive Rats.
Kazuyoshi Hara, Naohiko Kobayashi, Shigefumi Nakano, Yousuke Mori, Yusuke Tsubokou, Hiroaki Matsuoka
Hypertens Res 24(1):55. [CrossRef]
Inhibition of Intimal/Medial Hyperplasia by Perindopril in Canine Vein Grafts
J Flores, T Kunihara, N Shiiya, T Nishibe, F Kudo, K Yasuda
Ann Vasc Surg 19(4):499. [CrossRef]
Kazunori Yoshida, Masahiro Kohzuki, David Casley, Colin Johnston
J Cardiovasc Pharmacol 32(3):357. [CrossRef]
Deborah Siwik, R. Brown
J Cardiovasc Pharmacol 27(4):508. [CrossRef]
Wen-Yang Hu, Noboru Fukuda, Masayoshi Soma, Yoichi Izumi, Katsuo Kanmatsuse
J Cardiovasc Pharmacol 32(6):975. [CrossRef]
Jiro Kitayama, Takanari Kitazono, Hiroaki Ooboshi, Tetsuro Ago, Tetsuya Ohgami, Masatoshi Fujishima, Setsuro Ibayashi
J Hypertens 20(11):2205. [CrossRef]
Atsuo Tahara, Junko Tsukada, Yuichi Tomura, Toshiyuki Kusayama, Koh-ichi Wada, Noe Ishii, Takeyuki Yatsu, Wataru Uchida, Nobuaki Taniguchi, Akihiro Tanaka
J Hypertens 20(9):1807. [CrossRef]
Effect of NorLeu3-A(1-7) on scar formation over time after full-thickness incision injury in the rat
Kathleen E. Rodgers, Dolph D. Ellefson, Theresa Espinoza, Norma Roda, Sonia Maldonado, Gere S. Dizerega
Wound Repair Regen 13(3):309. [CrossRef]
Karin Jandeleit-dahm, Louise Burrell, Colin Johnston, Karl Koch
J Hypertens 15(6):643. [CrossRef]
Massimo Volpe, Beatrice Musumeci, Paola De paolis, Carmine Savoia, Alberto Morganti
J Hypertens 21(8):1429. [CrossRef]
Wen-Yang Hu, Noboru Fukuda, Katsuo Kanmatsuse
J Hypertens 20(7):1323. [CrossRef]
Novel signaling pathways contributing to vascular changes in hypertension
Douglas G. Johns, Anne M. Dorrance, Romulo Leite, David S. Weber, R. Clinton webb
J Biomed Sci 7(6):431. [CrossRef]
Larger Anastomoses in Angiotensinogen-Knockout Mice Attenuate Early Metabolic Disturbances After Middle Cerebral Artery Occlusion
Keiichiro Maeda, Ryuji Hata, Michael Bader, Thomas Walther, Konstantin-Alexander Hossmann
J Cereb Blood Flow Metab [CrossRef]
Hyperplastic vascular smooth muscle cells of the intrarenal arteries in angiotensin II type 1a receptor null mutant mice
Sachiko Inokuchi, Kenjiro Kimura, Takeshi Sugaya, Koiti Inokuchi, Kazuo Murakami, Tatsuo Sakai
Kidney Int 60(2):722. [CrossRef]
Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat
Attila Szabo, Jens Lutz, Karina Schleimer, Balazs Antus, Peter Hamar, Thomas Philipp, Uwe Heemann
Kidney Int 57(3):982. [CrossRef]
Effect of angiotensin converting enzyme inhibition on the incidence of restenosis after percutaneous transluminal coronary angioplasty
Frank V. Brozovich, Joel Morganroth, Neil B. Gottlieb, Ronald S. Gottlieb
Cathet Cardiovasc Diagn 23(4):263. [CrossRef]
Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer
Takeo Kosaka, Akira Miyajima, Eiji Takayama, Eiji Kikuchi, Jun Nakashima, Takashi Ohigashi, Tomohiko Asano, Michiie Sakamoto, Hajime Okita, Masaru Murai
Prostate 67(1):41. [CrossRef]
Combination of ACE Inhibitors and Calcium Antagonists: A Logical Approach
Frank T. Ruschitzka, Georg Noll, Thomas F. L??scher
J Cardiovasc Pharmacol 31(supplement 2):S5. [CrossRef]
Angiotensin II-receptor antagonist in the treatment of hypertension
Massimo Volpe, Giuliano Tocci, Erika Pagannone
Current Science Inc 7(4):287. [CrossRef]
SPARC is expressed in renal interstitial fibrosis and in renal vascular injury
Raimund H Pichler, Christian Hugo, Stuart J Shankland, May J Reed, James A Bassuk, Takeshi F Andoh, Donna M Lombardi, Stephen M Schwartz, William M Bennett, Charles E Alpers
Kidney Int 50(6):1978. [CrossRef]
Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition
Tsuyoshi Oikawa, Michael Freeman, Wilbur Lo, Douglas E Vaughan, Agnes Fogo
Kidney Int 51(1):164. [CrossRef]
Regulation of matrix proteins and impact on vascular structure
José Tuñón, Marta Ruiz-ortega, Jesús Egido
Current Science Inc 2(1):106. [CrossRef]
Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting-enzyme gene
Domingo Hernández, Juan Lacalzada, Margarita Rufino, Armando Torres, Natalia Martín, Antonio Barragán, Ysamar Barrios, Manuel Macía, Eduardo De bonis, Víctor Lorenzo
Kidney Int 51(4):1205. [CrossRef]
Intrarenal localization of angiotensin II type 1 receptor mRNA in the rat
Yoshihiko Kakinuma, Agnes Fogo, Tadashi Inagami, Iekuni Ichikawa
Kidney Int 43(6):1229. [CrossRef]
Antagonising the expression of VEGF in pathological angiogenesis
Paul EC Brenchley
eotp 8(12):1695. [CrossRef]
Does rapidity of blood pressure lowering affect outcomes in hypertension treatment?
David Wojciechowski, Vasilios Papademetriou
Curr Cardio Risk Rep 2(4):255. [CrossRef]
Effect of Angiotensin II on Hematopoietic Progenitor Cell Proliferation
K. E. Rodgers, S. Xiong, R. Steer, G. S. Dizerega
Stem Cells (Miamisburg) 18(4):287. [CrossRef]
Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma
David A. Walsh, De-En Hu, John Wharton, John D. Catravas, David R. Blake, Tai-Ping D. Fan
Br J Pharmacol 120(7):1302. [CrossRef]
